TDCMEDIUM SIGNALFINANCIAL10-K

Teradata delivered improved profitability with net income growing 14% while simultaneously strengthening its balance sheet through substantially higher stockholders' equity.

The company demonstrated operational discipline by reducing SG&A expenses while growing net income, suggesting effective cost management initiatives are taking hold. The notable increase in stockholders' equity combined with reduced share buyback activity indicates management is prioritizing balance sheet strengthening over aggressive capital returns to shareholders.

Comparing 2026-02-27 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

Teradata's financial position improved across multiple dimensions, with net income growing 14% to $130M while SG&A expenses declined 11.2%, demonstrating expanding operational efficiency. The balance sheet strengthened considerably with stockholders' equity rising substantially to $230M and cash increasing 17.4% to $493M. The company reduced share repurchases by 35% and lowered capital expenditures, suggesting a more conservative capital allocation approach focused on financial stability rather than aggressive growth investments.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+72.9%
$133.0M→$230.0M

Equity base grew 72.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Share Buybacks
Cash Flow
-34.9%
$215.0M→$140.0M

Buyback activity reduced 34.9% — capital being redeployed elsewhere or cash conservation underway.

Inventory
Balance Sheet
-27.8%
$18.0M→$13.0M

Inventory reduced 27.8% — lean inventory management or demand outpacing supply.

Interest Expense
P&L
+25%
$24.0M→$30.0M

Interest costs rose 25% — monitor debt levels and coverage ratio in rising rate environment.

Capital Expenditure
Cash Flow
-20.8%
$24.0M→$19.0M

Capex reduced 20.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
+17.4%
$420.0M→$493.0M

Cash grew 17.4% — improving liquidity position supports investment and shareholder returns.

Net Income
P&L
+14%
$114.0M→$130.0M

Net income grew 14% — bottom-line growth signals improving overall business health.

Current Assets
Balance Sheet
+11.7%
$749.0M→$837.0M

Current assets grew 11.7% — improving short-term liquidity or inventory/receivables build.

SG&A Expense
P&L
-11.2%
$565.0M→$502.0M

SG&A reduced 11.2% — improved cost efficiency or headcount reduction improving operating margins.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-02-21
ADDED
At January 30, 2026, there were 92.2 million shares of common stock outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 32 7A.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 83 9A.
At Teradata Corporation ("we," "us," "Teradata," or the "Company"), we are focused on helping organizations activate the intelligence in their enterprise and turn the insights from across their organization into outcomes.
In the agentic future, AI agents have enterprise context, can act on it in milliseconds and address continuous decisions at enterprise scale.
+7 more — sign up free →
REMOVED
At January 31, 2025, there were 94.6 million shares of common stock outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 33 7A.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 82 9A.
At Teradata Corporation ("we," "us," "Teradata," or the "Company"), we believe that people thrive when empowered with trusted information.
We are focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →